当前位置:首页 - 行情中心 - 博拓生物(688767) - 财务分析 - 现金流量表

博拓生物

(688767)

  

流通市值:60.21亿  总市值:60.21亿
流通股本:1.49亿   总股本:1.49亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金242,376,948.27130,230,518.92497,647,512.6386,481,114.18
  收到的税费返还7,270,887.414,837,527.5315,563,749.0511,024,554.13
  收到其他与经营活动有关的现金16,562,411.069,504,453.9669,100,748.0546,436,308.71
  经营活动现金流入小计266,210,246.74144,572,500.41582,312,009.7443,941,977.02
  购买商品、接受劳务支付的现金109,148,301.4555,319,909.32257,201,923.77174,260,935.07
  支付给职工以及为职工支付的现金60,498,555.2633,397,141.48125,841,894.3388,905,690.34
  支付的各项税费20,292,655.513,105,840.2115,294,504.7736,700,190.16
  支付其他与经营活动有关的现金29,277,532.515,176,640.4555,148,248.1735,057,081.4
  经营活动现金流出小计219,217,044.71116,999,531.46453,486,571.04334,923,896.97
  经营活动产生的现金流量净额46,993,202.0327,572,968.95128,825,438.66109,018,080.05
二、投资活动产生的现金流量:
  收回投资收到的现金3,409,866,6002,196,124,8006,391,955,0003,607,000,000
  取得投资收益收到的现金4,443,718.762,633,975.488,542,262.075,605,046.36
  处置固定资产、无形资产和其他长期资产收回的现金净额265,000-80,589.98-
  投资活动现金流入小计3,414,575,318.762,198,758,775.486,400,577,852.053,612,605,046.36
  购建固定资产、无形资产和其他长期资产支付的现金19,987,707.699,966,824.62245,054,559.46232,270,705.08
  投资支付的现金2,833,825,0001,639,124,8006,993,774,448.83,648,823,550
  投资活动现金流出小计2,853,812,707.691,649,091,624.627,238,829,008.263,881,094,255.08
  投资活动产生的现金流量净额560,762,611.07549,667,150.86-838,251,156.21-268,489,208.72
三、筹资活动产生的现金流量:
  收到其他与筹资活动有关的现金3,147,500-24,871,000-
  筹资活动现金流入平衡项目0-0-
  筹资活动现金流入小计3,147,500-24,871,000-
  偿还债务支付的现金211,721.07-148,252.84289,741.79
  分配股利、利润或偿付利息支付的现金159,875,000.553,208,333.583,645,463.281,936,212.66
  支付其他与筹资活动有关的现金1,325,772.72-45,630,753.5544,969,473.56
  筹资活动现金流出小计161,412,494.2953,208,333.5129,424,469.59127,195,428.01
  筹资活动产生的现金流量净额-158,264,994.29-53,208,333.5-104,553,469.59-127,195,428.01
四、汇率变动对现金及现金等价物的影响-2,908,169.22-429,699.3210,499,922.62-10,692,163.36
五、现金及现金等价物净增加额446,582,649.59523,602,086.99-803,479,264.52-297,358,720.04
  加:期初现金及现金等价物余额1,103,759,431.161,103,759,431.161,907,238,695.681,907,238,695.68
  期末现金及现金等价物余额1,550,342,080.751,627,361,518.151,103,759,431.161,609,879,975.64
补充资料:
  净利润10,741,062.69-166,775,401.55-
  资产减值准备900,521.34-22,794,092.71-
  固定资产和投资性房地产折旧11,456,391.63-20,122,823.78-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧11,456,391.63-20,122,823.78-
  无形资产摊销2,860,886.89-1,144,069.23-
  长期待摊费用摊销--108,266.15-
  处置固定资产、无形资产和其他长期资产的损失-278,156.7-334,430.28-
  固定资产报废损失10,993.15---
  公允价值变动损失---257,796.83-
  财务费用2,342,569.22--9,100,169.71-
  投资损失-3,124,451.6--6,789,817.56-
  递延所得税668,655.75-1,937,045.92-
  其中:递延所得税资产减少668,655.75-2,645,376.54-
    递延所得税负债增加---708,330.62-
  存货的减少1,441,308.85-3,128,800.1-
  经营性应收项目的减少20,640,388.09--39,775,742.43-
  经营性应付项目的增加-7,977,288.57--43,094,634.93-
  其他8,584,106.85-6,525,651.84-
  现金的期末余额1,550,342,080.75-1,103,759,431.16-
  减:现金的期初余额1,103,759,431.16-1,907,238,695.68-
  现金及现金等价物的净增加额446,582,649.59--803,479,264.52-
公告日期2025-08-292025-04-262025-04-262024-10-30
审计意见(境内)标准无保留意见
TOP↑